Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jun;65(6):2112–2118. doi: 10.1128/iai.65.6.2112-2118.1997

Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

S R Klee 1, B D Tzschaschel 1, I Fält 1, A Kärnell 1, A A Lindberg 1, K N Timmis 1, C A Guzmán 1
PMCID: PMC175292  PMID: 9169740

Abstract

Vaccine candidates against Shigella dysenteriae type 1, which is associated with the most severe cases of bacillary dysentery, were constructed. The rfp and rfb gene clusters, which code for S. dysenteriae 1 O antigen biosynthesis, were randomly integrated into either the chromosome or the virulence plasmid of the rough attenuated Shigella flexneri aroD strain SFL124-27 with a minitransposon carrying an arsenite resistance selection marker. The recombinant clones efficiently expressed the recombinant O antigen, exhibited a normal growth pattern, were able to invade and survive within eukaryotic cells to the same extent as the parental strain, and expressed the recombinant antigen within invaded cells. A clone was selected as the vaccine candidate, which was demonstrated to be immunogenic and safe in animal models, leading to 47% full protection and 53% partial protection against challenge with the wild-type strain.

Full Text

The Full Text of this article is available as a PDF (690.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Attridge S. R., Daniels D., Morona J. K., Morona R. Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210. Microb Pathog. 1990 Mar;8(3):177–188. doi: 10.1016/0882-4010(90)90045-r. [DOI] [PubMed] [Google Scholar]
  2. Baron L. S., Kopecko D. J., Formal S. B., Seid R., Guerry P., Powell C. Introduction of Shigella flexneri 2a type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a. Infect Immun. 1987 Nov;55(11):2797–2801. doi: 10.1128/iai.55.11.2797-2801.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennish M. L., Harris J. R., Wojtyniak B. J., Struelens M. Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis. 1990 Mar;161(3):500–506. doi: 10.1093/infdis/161.3.500. [DOI] [PubMed] [Google Scholar]
  4. Chen C. M., Misra T. K., Silver S., Rosen B. P. Nucleotide sequence of the structural genes for an anion pump. The plasmid-encoded arsenical resistance operon. J Biol Chem. 1986 Nov 15;261(32):15030–15038. [PubMed] [Google Scholar]
  5. Chu C. Y., Liu B. K., Watson D., Szu S. S., Bryla D., Shiloach J., Schneerson R., Robbins J. B. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun. 1991 Dec;59(12):4450–4458. doi: 10.1128/iai.59.12.4450-4458.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DuPont H. L., Levine M. M., Hornick R. B., Formal S. B. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis. 1989 Jun;159(6):1126–1128. doi: 10.1093/infdis/159.6.1126. [DOI] [PubMed] [Google Scholar]
  7. Fontaine A., Arondel J., Sansonetti P. J. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1. Infect Immun. 1988 Dec;56(12):3099–3109. doi: 10.1128/iai.56.12.3099-3109.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fält I. C., Schweda E. K., Klee S., Singh M., Floderus E., Timmis K. N., Lindberg A. A. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes. J Bacteriol. 1995 Sep;177(18):5310–5315. doi: 10.1128/jb.177.18.5310-5315.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldberg M. B., Sansonetti P. J. Shigella subversion of the cellular cytoskeleton: a strategy for epithelial colonization. Infect Immun. 1993 Dec;61(12):4941–4946. doi: 10.1128/iai.61.12.4941-4946.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Göhmann S., Manning P. A., Alpert C. A., Walker M. J., Timmis K. N. Lipopolysaccharide O-antigen biosynthesis in Shigella dysenteriae serotype 1: analysis of the plasmid-carried rfp determinant. Microb Pathog. 1994 Jan;16(1):53–64. doi: 10.1006/mpat.1994.1005. [DOI] [PubMed] [Google Scholar]
  11. Hale T. L., Guerry P., Seid R. C., Jr, Kapfer C., Wingfield M. E., Reaves C. B., Baron L. S., Formal S. B. Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1. Infect Immun. 1984 Nov;46(2):470–475. doi: 10.1128/iai.46.2.470-475.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Halling S. M., Simons R. W., Way J. C., Walsh R. B., Kleckner N. DNA sequence organization of IS10-right of Tn10 and comparison with IS10-left. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2608–2612. doi: 10.1073/pnas.79.8.2608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hartman A. B., Powell C. J., Schultz C. L., Oaks E. V., Eckels K. H. Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Infect Immun. 1991 Nov;59(11):4075–4083. doi: 10.1128/iai.59.11.4075-4083.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hartman A. B., Van de Verg L. L., Collins H. H., Jr, Tang D. B., Bendiuk N. O., Taylor D. N., Powell C. J. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. Infect Immun. 1994 Feb;62(2):412–420. doi: 10.1128/iai.62.2.412-420.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Herrero M., de Lorenzo V., Timmis K. N. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J Bacteriol. 1990 Nov;172(11):6557–6567. doi: 10.1128/jb.172.11.6557-6567.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Herrington D. A., Van de Verg L., Formal S. B., Hale T. L., Tall B. D., Cryz S. J., Tramont E. C., Levine M. M. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine. 1990 Aug;8(4):353–357. doi: 10.1016/0264-410x(90)90094-3. [DOI] [PubMed] [Google Scholar]
  17. Hitchcock P. J., Brown T. M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol. 1983 Apr;154(1):269–277. doi: 10.1128/jb.154.1.269-277.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kado C. I., Liu S. T. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol. 1981 Mar;145(3):1365–1373. doi: 10.1128/jb.145.3.1365-1373.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kadurugamuwa J. L., Rohde M., Wehland J., Timmis K. N. Intercellular spread of Shigella flexneri through a monolayer mediated by membranous protrusions and associated with reorganization of the cytoskeletal protein vinculin. Infect Immun. 1991 Oct;59(10):3463–3471. doi: 10.1128/iai.59.10.3463-3471.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Klena J. D., Ashford R. S., 2nd, Schnaitman C. A. Role of Escherichia coli K-12 rfa genes and the rfp gene of Shigella dysenteriae 1 in generation of lipopolysaccharide core heterogeneity and attachment of O antigen. J Bacteriol. 1992 Nov;174(22):7297–7307. doi: 10.1128/jb.174.22.7297-7307.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kreuzer K., Pratt C., Torriani A. Genetic analysis of regulatory mutants of alkaline phosphatase of E. coli. Genetics. 1975 Nov;81(3):459–468. doi: 10.1093/genetics/81.3.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kärnell A., Stocker B. A., Katakura S., Reinholt F. P., Lindberg A. A. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies. Vaccine. 1992;10(6):389–394. doi: 10.1016/0264-410x(92)90069-v. [DOI] [PubMed] [Google Scholar]
  23. Kärnell A., Sweiha H., Lindberg A. A. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes. Vaccine. 1992;10(3):167–174. doi: 10.1016/0264-410x(92)90007-7. [DOI] [PubMed] [Google Scholar]
  24. Lesse A. J., Campagnari A. A., Bittner W. E., Apicella M. A. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Methods. 1990 Jan 24;126(1):109–117. doi: 10.1016/0022-1759(90)90018-q. [DOI] [PubMed] [Google Scholar]
  25. Levine M. M. Bacillary dysentery: mechanisms and treatment. Med Clin North Am. 1982 May;66(3):623–638. doi: 10.1016/s0025-7125(16)31411-0. [DOI] [PubMed] [Google Scholar]
  26. Li A., Cam P. D., Islam D., Minh N. B., Huan P. T., Rong Z. C., Karlsson K., Lindberg G., Lindberg A. A. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124. J Infect. 1994 Jan;28(1):11–23. doi: 10.1016/s0163-4453(94)94006-1. [DOI] [PubMed] [Google Scholar]
  27. Li A., Kärnell A., Huan P. T., Cam P. D., Minh N. B., Trâm L. N., Quy N. P., Trach D. D., Karlsson K., Lindberg G. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers. Vaccine. 1993;11(2):180–189. doi: 10.1016/0264-410x(93)90015-p. [DOI] [PubMed] [Google Scholar]
  28. Li A., Pál T., Forsum U., Lindberg A. A. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers. Vaccine. 1992;10(6):395–404. doi: 10.1016/0264-410x(92)90070-z. [DOI] [PubMed] [Google Scholar]
  29. Lindberg A. A., Karnell A., Pál T., Sweiha H., Hultenby K., Stocker B. A. Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. Microb Pathog. 1990 Jun;8(6):433–440. doi: 10.1016/0882-4010(90)90030-t. [DOI] [PubMed] [Google Scholar]
  30. Lindberg A. A., Pál T. Strategies for development of potential candidate Shigella vaccines. Vaccine. 1993;11(2):168–179. doi: 10.1016/0264-410x(93)90014-o. [DOI] [PubMed] [Google Scholar]
  31. Lopez E. L., Diaz M., Grinstein S., Devoto S., Mendilaharzu F., Murray B. E., Ashkenazi S., Rubeglio E., Woloj M., Vasquez M. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis. 1989 Sep;160(3):469–475. doi: 10.1093/infdis/160.3.469. [DOI] [PubMed] [Google Scholar]
  32. Mallett C. P., VanDeVerg L., Collins H. H., Hale T. L. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine. 1993;11(2):190–196. doi: 10.1016/0264-410x(93)90016-q. [DOI] [PubMed] [Google Scholar]
  33. Mason P. R., Nathoo K. J., Wellington M., Mason E. Antimicrobial susceptibilities of Shigella dysenteriae type 1 isolated in Zimbabwe--implications for the management of dysentery. Cent Afr J Med. 1995 Apr;41(4):132–137. [PubMed] [Google Scholar]
  34. Meitert T., Pencu E., Ciudin L., Tonciu M. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati). Arch Roum Pathol Exp Microbiol. 1984 Jul-Dec;43(3-4):251–278. [PubMed] [Google Scholar]
  35. Newland J. W., Hale T. L., Formal S. B. Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen. Vaccine. 1992;10(11):766–776. doi: 10.1016/0264-410x(92)90512-i. [DOI] [PubMed] [Google Scholar]
  36. Noriega F. R., Wang J. Y., Losonsky G., Maneval D. R., Hone D. M., Levine M. M. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immun. 1994 Nov;62(11):5168–5172. doi: 10.1128/iai.62.11.5168-5172.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Oberhelman R. A., Kopecko D. J., Salazar-Lindo E., Gotuzzo E., Buysse J. M., Venkatesan M. M., Yi A., Fernandez-Prada C., Guzman M., León-Barúa R. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect Immun. 1991 Jul;59(7):2341–2350. doi: 10.1128/iai.59.7.2341-2350.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Okada N., Sasakawa C., Tobe T., Yamada M., Nagai S., Talukder K. A., Komatsu K., Kanegasaki S., Yoshikawa M. Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis. Mol Microbiol. 1991 Jan;5(1):187–195. doi: 10.1111/j.1365-2958.1991.tb01839.x. [DOI] [PubMed] [Google Scholar]
  39. Pal S. C., Sengupta P. G., Sen D., Bhattacharya S. K., Deb B. C. Epidemic shigellosis due to Shigella dysenteriae type 1 in south Asia. Indian J Med Res. 1989 Mar;89:57–64. [PubMed] [Google Scholar]
  40. SERENY B. Experimental keratoconjunctivitis shigellosa. Acta Microbiol Acad Sci Hung. 1957;4(4):367–376. [PubMed] [Google Scholar]
  41. Sandlin R. C., Lampel K. A., Keasler S. P., Goldberg M. B., Stolzer A. L., Maurelli A. T. Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect Immun. 1995 Jan;63(1):229–237. doi: 10.1128/iai.63.1.229-237.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sansonetti P. J., Arondel J., Fontaine A., d'Hauteville H., Bernardini M. L. OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis. Vaccine. 1991 Jun;9(6):416–422. doi: 10.1016/0264-410x(91)90128-s. [DOI] [PubMed] [Google Scholar]
  43. Sansonetti P. J., Kopecko D. J., Formal S. B. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982 Mar;35(3):852–860. doi: 10.1128/iai.35.3.852-860.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sasakawa C., Kamata K., Sakai T., Murayama S. Y., Makino S., Yoshikawa M. Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect Immun. 1986 Feb;51(2):470–475. doi: 10.1128/iai.51.2.470-475.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Seid R. C., Jr, Kopecko D. J., Sadoff J. C., Schneider H., Baron L. S., Formal S. B. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. J Biol Chem. 1984 Jul 25;259(14):9028–9034. [PubMed] [Google Scholar]
  46. Sturm S., Jann B., Jann K., Fortnagel P., Timmis K. N. Genetic and biochemical analysis of Shigella dysenteriae 1 O antigen polysaccharide biosynthesis in Escherichia coli K-12: structure and functions of the rfb gene cluster. Microb Pathog. 1986 Jun;1(3):307–324. doi: 10.1016/0882-4010(86)90056-2. [DOI] [PubMed] [Google Scholar]
  47. Sturm S., Timmis K. N. Cloning of the rfb gene region of Shigella dysenteriae 1 and construction of an rfb-rfp gene cassette for the development of lipopolysaccharide-based live anti-dysentery vaccines. Microb Pathog. 1986 Jun;1(3):289–297. doi: 10.1016/0882-4010(86)90054-9. [DOI] [PubMed] [Google Scholar]
  48. Taylor D. N., Bodhidatta L., Brown J. E., Echeverria P., Kunanusont C., Naigowit P., Hanchalay S., Chatkaeomorakot A., Lindberg A. A. Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand. Am J Trop Med Hyg. 1989 Jan;40(1):77–85. doi: 10.4269/ajtmh.1989.40.77. [DOI] [PubMed] [Google Scholar]
  49. Taylor D. N., Trofa A. C., Sadoff J., Chu C., Bryla D., Shiloach J., Cohen D., Ashkenazi S., Lerman Y., Egan W. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect Immun. 1993 Sep;61(9):3678–3687. doi: 10.1128/iai.61.9.3678-3687.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tsai C. M., Frasch C. E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982 Jan 1;119(1):115–119. doi: 10.1016/0003-2697(82)90673-x. [DOI] [PubMed] [Google Scholar]
  51. Tzschaschel B. D., Klee S. R., de Lorenzo V., Timmis K. N., Guzmán C. A. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain. Microb Pathog. 1996 Oct;21(4):277–288. doi: 10.1006/mpat.1996.0061. [DOI] [PubMed] [Google Scholar]
  52. Verma N. K., Lindberg A. A. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes. Vaccine. 1991 Jan;9(1):6–9. doi: 10.1016/0264-410x(91)90308-s. [DOI] [PubMed] [Google Scholar]
  53. Viret J. F., Cryz S. J., Jr, Lang A. B., Favre D. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains. Mol Microbiol. 1993 Jan;7(2):239–252. doi: 10.1111/j.1365-2958.1993.tb01115.x. [DOI] [PubMed] [Google Scholar]
  54. Watanabe H., Timmis K. N. A small plasmid in Shigella dysenteriae 1 specifies one or more functions essential for O antigen production and bacterial virulence. Infect Immun. 1984 Jan;43(1):391–396. doi: 10.1128/iai.43.1.391-396.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Winsor D. K., Jr, Mathewson J. J., DuPont H. L. Comparison of serum and fecal antibody responses of patients with naturally acquired Shigella sonnei infection. J Infect Dis. 1988 Nov;158(5):1108–1112. doi: 10.1093/infdis/158.5.1108. [DOI] [PubMed] [Google Scholar]
  56. de Lorenzo V., Eltis L., Kessler B., Timmis K. N. Analysis of Pseudomonas gene products using lacIq/Ptrp-lac plasmids and transposons that confer conditional phenotypes. Gene. 1993 Jan 15;123(1):17–24. doi: 10.1016/0378-1119(93)90533-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES